| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 63 | 7.697 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.155 | 9.892 | 12 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 23.079 | 12.683 | 6.369 | 4.918 | 3.899 | 4.027 | 3.038 | 3.055 | 2.181 | 2.131 |
| Gross Profit/Loss - EUR | -20.924 | -2.791 | -6.357 | -4.916 | -3.899 | -4.027 | -3.038 | -3.055 | -2.181 | -2.131 |
| Net Profit/Loss - EUR | -20.926 | -3.022 | -6.357 | -4.916 | -3.899 | -4.027 | -3.050 | -3.055 | -2.181 | -2.131 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mediquest Clinical Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 56.717 | 52.463 | 47.976 | 43.583 | 39.294 | 35.170 | 31.085 | 28.183 | 26.215 | 24.197 |
| Current Assets | 11.079 | 3.066 | 1.926 | 1.964 | 1.996 | 1.778 | 1.290 | 1.246 | 1.461 | 1.417 |
| Inventories | 1.707 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.767 | 873 | 1.143 | 1.197 | 1.248 | 1.303 | 1.223 | 1.238 | 1.234 | 1.233 |
| Cash | 6.604 | 2.193 | 782 | 768 | 745 | 475 | 67 | 8 | 227 | 184 |
| Shareholders Funds | -41.951 | -44.545 | -50.148 | -54.144 | -56.994 | -59.940 | -61.661 | -64.908 | -66.892 | -68.649 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 109.747 | 100.142 | 100.050 | 99.691 | 98.284 | 96.888 | 94.037 | 94.337 | 94.568 | 94.263 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Mediquest Clinical Research Srl